673 Stock Overview
An investment holding company, engages in the distribution and services of medical equipment and consumables in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
China Health Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.63 |
| 52 Week High | HK$1.35 |
| 52 Week Low | HK$0.52 |
| Beta | -0.55 |
| 11 Month Change | -4.55% |
| 3 Month Change | -21.25% |
| 1 Year Change | -47.93% |
| 33 Year Change | -10.00% |
| 5 Year Change | -46.15% |
| Change since IPO | -99.34% |
Recent News & Updates
Recent updates
Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns
Sep 05
Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation
Sep 11We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt
Dec 01We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet
Sep 23We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation
Sep 02Did China Health Group Limited (HKG:673) Insiders Sell Shares?
Feb 16
Shareholder Returns
| 673 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -4.5% | -4.4% | -1.0% |
| 1Y | -47.9% | -24.2% | 20.3% |
Return vs Industry: 673 underperformed the Hong Kong Healthcare industry which returned -24.2% over the past year.
Return vs Market: 673 underperformed the Hong Kong Market which returned 20.3% over the past year.
Price Volatility
| 673 volatility | |
|---|---|
| 673 Average Weekly Movement | 10.3% |
| Healthcare Industry Average Movement | 7.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 673 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 673's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 127 | Ho Chung | www.ch-groups.com |
China Health Group Limited, an investment holding company, engages in the distribution and services of medical equipment and consumables in the People’s Republic of China. The company operates through Distribution and Service in Medical Equipment and Consumables; Hospital Operation and Management Services; Business Service; and Research and Development and Sale of Functional Food segments. It is involved in the distribution and marketing of pharmaceutical products, as well as property investment and factoring services business.
China Health Group Limited Fundamentals Summary
| 673 fundamental statistics | |
|---|---|
| Market cap | HK$309.74m |
| Earnings (TTM) | -HK$40.19m |
| Revenue (TTM) | HK$59.93m |
5.2x
P/S Ratio-7.7x
P/E RatioIs 673 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 673 income statement (TTM) | |
|---|---|
| Revenue | HK$59.93m |
| Cost of Revenue | HK$46.29m |
| Gross Profit | HK$13.64m |
| Other Expenses | HK$53.83m |
| Earnings | -HK$40.19m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.082 |
| Gross Margin | 22.76% |
| Net Profit Margin | -67.06% |
| Debt/Equity Ratio | 9.2% |
How did 673 perform over the long term?
See historical performance and comparison